NRC HEALTH (NRC)

Services-Commercial Physical & Biological Research

Latest Price

$21.96

TTM P/E

0.44

Normalized P/E

2.02

Div Yield

2.73%

Book Value

0.30

P/B Ratio

73.44

Valuation metrics

EPS: $50.00

Book value / share: $0.62

Formula: √(22.5 × EPS × BVPS)

Graham Number

$26.37

+20% upside

Norm. op. income: $43M (median of 7yr)

Tax rate: 23%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$11.40

48% downside

Base FCF: $22M (median of recent 5yr)

Growth: -15%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$1.18

95% downside

EPS: $50.00

Target P/E: 2×

Formula: EPS × P/E

P/E Fair Value

$100.00

+355% upside

45.6% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC	2.03M	$43.0M	9.17%	-605.9K	2026-06-30
BlackRock, Inc.	1.06M	$22.0M	4.79%	+85.5K	2026-06-30
MORGAN STANLEY	859.3K	$18.0M	3.88%	-142.6K	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	666.6K	$14.0M	3.01%	+3.7K	2026-06-30
DIMENSIONAL FUND ADVISORS LP	491.2K	$10.0M	2.22%	+1.5K	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	420.1K	$9.0M	1.90%	+26.2K	2026-06-30
QV Investors Inc.	372.5K	$8.0M	1.68%	-8.8K	2026-06-30
RENAISSANCE TECHNOLOGIES LLC	325.4K	$7.0M	1.47%	-15.4K	2026-06-30
HEARTLAND ADVISORS INC	300.0K	$6.0M	1.36%	+62.9K	2026-06-30
STATE STREET CORP	298.4K	$6.0M	1.35%	-2.4K	2026-06-30